DS
PDSB icon

David Shaw’s PDS Biotechnology PDSB Stock Holding History

David Shaw’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49,695
Closed -$247K – 4635
2023
Q4 		$247K Buy
+49,695
New +$247K ﹤0.01% 3814
2023
Q2 		– Sell
-162,769
Closed -$1M – 4470
2023
Q1 		$1M Sell
162,769
-176,909
-52% -$1.45M ﹤0.01% 3165
2022
Q4 		$4.48M Buy
339,678
+324,774
+2,179% +$2.29M 0.01% 2204
2022
Q3 		$44K Buy
+14,904
New +$63.2K ﹤0.01% 4703
2022
Q2 		– Sell
-83,112
Closed -$514K – 5663
2022
Q1 		$514K Buy
83,112
+53,507
+181% +$332K ﹤0.01% 4355
2021
Q4 		$240K Buy
+29,605
New +$319K ﹤0.01% 4791
2020
Q2 		– Sell
-13,281
Closed -$10K – 4203
2020
Q1 		$10K Hold
13,281
– – ﹤0.01% 3866
2019
Q4 		$35K Sell
13,281
-397
-3% -$1.13K ﹤0.01% 3905
2019
Q3 		$46K Hold
13,678
– – ﹤0.01% 3730
2019
Q2 		$82K Sell
13,678
-25,256
-65% -$165K ﹤0.01% 3563
2019
Q1 		$288K Buy
38,934
+1,746
+5% +$14.6K ﹤0.01% 3237
2018
Q4 		$238K Sell
37,188
-798
-2% -$10.6K ﹤0.01% 3468
2018
Q3 		$623K Sell
37,986
-4,847
-11% -$87.1K ﹤0.01% 2978
2018
Q2 		$883K Buy
42,833
+41,085
+2,350% +$857K ﹤0.01% 2775
2018
Q1 		$41K Buy
1,748
+292
+20% +$78.5K ﹤0.01% 3431
2017
Q4 		$273K Buy
1,456
+170
+13% +$34.2K ﹤0.01% 3279
2017
Q3 		$276K Buy
1,286
+135
+12% +$27.9K ﹤0.01% 3176
2017
Q2 		$236K Sell
1,151
-256
-18% -$50.4K ﹤0.01% 3132
2017
Q1 		$256K Buy
1,407
+498
+55% +$98.6K ﹤0.01% 3034
2016
Q4 		$227K Buy
+909
New +$207K ﹤0.01% 3226
2016
Q2 		– Sell
-613
Closed -$112K – 3483
2016
Q1 		$112K Sell
613
-1,100
-64% -$197K ﹤0.01% 3274
2015
Q4 		$428K Buy
+1,713
New +$552K ﹤0.01% 3173

Other funds holding PDSB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

David Shaw's PDSB Position: Q1 2024 in Review

David Shaw sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 49,695 shares — an estimated $247K sold.

David Shaw first reported a position in PDSB in Q4 2015 and held it in 22 quarters. The position peaked at $4.48M in Q4 2022. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • David Shaw reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 49,695 PDS Biotechnology shares in Q1 2024, an estimated $247K.
  • David Shaw first reported a position in PDS Biotechnology in Q4 2015 and held it in 22 quarters.
  • David Shaw's PDS Biotechnology position peaked at $4.48M in Q4 2022.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.